Image Analysis Group

IAG is a leading imaging clinical research organization that combines medical and operational expertise with proprietary cloud-based platform DYNAMIKA for data management and a Category Award Winner for Innovation.

IFF Pharma Solutions 

IFF  the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products and a Category Award Winner for Marketing.

Syngene

Syngene is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors and a Category Award Winner for Innovation, Business Expansion, and Environmental.

PCI Pharma Services 

PCI Pharma Services, a leading contract development and manufacturing organization and a Category Award Winner for Innovation, Business Expansion.

BostonGene

BostonGene is a biotechnology company specializing in advanced computational biology and precision medicine. It is also a Category Award Winner for Business Expansion, Research and Development (R&D), Innovation, Product Launches and Marketing.

EMIS

EMIS is the UK’s leading integrated healthcare technology provider and a Category Award Winner for Innovation.

Medidata

Medidata Solutions (Medidata), a leading provider of clinical trial solutions to the life sciences industry, is part of Dassault Systèmes and a Category Award Winner for Innovation and Product Launches.

West Pharmaceutical Services

West is a leading provider of innovative, high-quality injectable solutions and services. It is also a Category Award Winner for Safety.

Botanical Solution Inc

Botanical Solution Inc. (BSI) is the world’s leading producer of Advanced Botanical Materials (ABM) that sustainably enable the production of gold-standard solutions for human and plant health and a Category Award Winner for Innovation and Business Expansion.

SecureCHEK AI

SecureCHEK AI is a SaaS provider specializing in AI-powered solutions and a Category Award Winner for Innovation, Marketing, Product Launches, and Diversity.

Catalent

Catalent is a leading global contract development and manufacturing organization (CDMO) and a Category Award Winner for Innovation and Social.

Our research for the 2024 Pharmaceutical Technology Excellence Awards has identified several key themes and trends that are shaping the pharmaceuticals industry. A significant focus is on innovation, particularly in the integration of AI and digital platforms to enhance drug discovery and development processes. Companies like 1910 Genetics and Dyno Therapeutics are leveraging AI to overcome critical challenges in CNS therapeutics and gene therapy, respectively. Similarly, SecureCHEK AI is making strides in compliance and regulatory operations by integrating Generative AI, which streamlines content creation and approval processes, ensuring both innovation and compliance.

Sustainability is another major trend, with companies like Bayer and Syngene leading the way in sustainable packaging and reducing carbon footprints, reflecting the industry’s commitment to environmental responsibility. Botanical Solution is also noteworthy for its sustainable production of QS-21, a vaccine adjuvant, which avoids deforestation and enhances accessibility.

Business expansion remains a prominent theme, with companies such as OmniaBio and Eton Pharmaceuticals investing in new facilities and strategic acquisitions to bolster their capabilities in regenerative medicine and rare diseases. PCI Pharma Services is expanding its injectable drug delivery infrastructure, demonstrating a commitment to growth and innovation. This expansion is often coupled with efforts to improve global access to advanced therapies, as seen with OmniaBio’s initiatives in Canada.

Social responsibility and diversity are at the forefront, with initiatives from Novo Nordisk and Pfizer highlighting efforts to address childhood obesity and promote social justice. SecureCHEK AI and Chugai Pharmaceutical are recognized for their leadership in promoting gender diversity and empowering women in the workplace. Catalent’s community engagement programs further exemplify the industry’s dedication to social impact.

The industry is also witnessing a surge in strategic mergers and acquisitions, as demonstrated by AstraZeneca’s acquisition of Fusion Pharmaceuticals and AbbVie’s acquisition of ImmunoGen, aimed at strengthening oncology and immunology pipelines. This trend underscores the importance of collaboration and consolidation in driving innovation and expanding therapeutic offerings.

Furthermore, companies like BostonGene and Medidata are advancing digital platforms that enhance clinical trial processes and data management, while West Pharmaceutical Services is setting new standards in safety culture through behavioural safety initiatives. Syngene’s integration of AI in drug discovery and IFF Pharma Solutions’ brand leadership in controlled release technologies highlight the diverse areas of innovation within the sector.

Overall, the 2024 awards highlight a dynamic industry that is rapidly evolving through technological advancements, strategic growth, and a strong commitment to social and environmental responsibility. Congratulations to all our Winners!